NDC 10797-995-01 - adequan i.m.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10797-995
- Requested NDC
- 10797-995-01
- Package NDCs from labels
- 10797-995-94, 10797-995-85, 10797-995-01, 10797-995-70
- Manufacturer
- American Regent, Inc.
- Effective date
- 2026-05-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| adequan polysulphated glycosaminoglycan solution for injection - UK | American Regent, Inc. | 2026-05-21 | PRESCRIPTION ANIMAL DRUG LABEL |
| ADEQUAN INTRAMUSCULAIRE 500 MG/5 ML SOLUTION INJECTABLE | American Regent, Inc. | 2026-05-19 | PRESCRIPTION ANIMAL DRUG LABEL |
| Adequan i.m. - American Regent, Inc. | Daiichi Sankyo Altrich Sari | American Regent, Inc. | Daiichi Sankyo Altrich Sari | 2024-10-07 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10797-995-01 | Adequan i.m. | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 5 | 10 | |
| 10797-995-70 | Adequan i.m. | 7 in 1 CARTON | INJECTION, SOLUTION | 7 | 10 | |
| 10797-995-94 | adequan i.m. | 7 in 1 CARTON | INJECTION, SOLUTION | 7 | 3 | |
| 10797-995-94 | adequan i.m. | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 3 | |
| 10797-995-85 | adequan i.m. | 7 in 1 CARTON | INJECTION, SOLUTION | 7 | 2 | |
| 10797-995-85 | adequan i.m. | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| polysulfated glycosaminoglycan | ACTIVE INGREDIENT | 268AW7000T | ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.] | 1 | |
| polysulfated glycosaminoglycan | ACTIVE MOIETY | 268AW7000T | ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Homeoplex B | ARSENICUM ALBUM, CALCAREA CARBONICA , IGNATIA AMARA, KALI CARBONICUM, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA, STAPHYSAGRIA | Supplement Clinic, LLC. | e9a9c58e-1b70-4ac8-9d9c-108c628d7664 | 2017-10-31 | Warnings | 451W47IQ8X |
| Spleen-Pro T018 | SPLEEN (SUIS), ARSENICUM ALBUM, CARBO VEGETABILIS, CEANOTHUS AMERICANUS, CHININUM SULPHURICUM, IGNATIA AMARA, IODIUM, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS | Guangzhou Renuma Medical Systems Co., Ltd | bc2b70bd-2a4a-46fb-b3d8-d69b61056b89 | 2017-10-26 | Warnings | 451W47IQ8X |
| Female Vitality T010 | CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, OOPHORINUM (SUIS), HYPOPHYSIS SUIS, THYROIDINUM (SUIS), GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA | Guangzhou Renuma Medical Systems Co., Ltd | 694f0c36-b656-471a-9f38-2efb5193e05a | 2017-10-20 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Company | 886f889b-f3cf-4197-b307-6cfa88c89436 | 2017-05-04 | 451W47IQ8X | |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | 451W47IQ8X |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.